SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShearwater Regulatory News (SWG)

Share Price Information for Shearwater (SWG)

Share Price is delayed by 15 minutes
Get Live Data
37.00    -0.50 (-1.33%)
Bid:
36.00
Ask:
38.00
Spread: 2.00 (5.556%)
Market Cap: £8.82m
SWG Live PriceLast checked at - London Stock Exchange

Intraday Shearwater Share Chart

Form 8.3 - Scott Wilson Group

14 Jun 2010 14:40

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Identity of the person whose positions/dealings are Gartmore Investment being disclosed:

Management Ltd (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose Scott Wilson Group relevant securities this form relates:

Plc Use a separate form for each offeror/offeree (d) If an exempt fund manager connected with an offeror/ offeree, state this and specify identity of offeror/ offeree: (e) Date position held/dealing undertaken: 11/06/10 (f) Has the discloser previously disclosed, or are they Yes today disclosing, under the Code in respect of any other party to this offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary GBP 0.01 Interests Short positions Number % Number % (1) Relevant securities owned 2,552,306 3.47% and/or controlled: (2) Derivatives (other than 864,190 1.17% options): (3) Options and agreements to purchase/sell: TOTAL: 3,416,496 4.64%

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other executive options)

Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages:

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit

security securities

(b) Derivatives transactions (other than options)

Class of Product Nature of dealing Number of Price per relevant description e.g. opening/closing a reference unit security e.g. CFD long/short position, securities increasing/reducing a long/short position CFD Increasing a long 36,780 £1.2337 position CFD Increasing a long 100,000 £1.2306 position CFD Increasing a long 25,000 £1.1585 position

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option relevant description purchasing, securities price e.g. date money security e.g. call selling, to which per unit American, paid/

option varying option European received etc. relates etc. per unit (ii) Exercising

Class of relevant Product Number of Exercise price per security description securities unit e.g. call option

(d) Other dealings (including subscribing for new securities)

Class of relevant Nature of dealing Details Price per unit

security e.g. subscription, (if applicable) conversion

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 14/06/10 Contact name: Alison Averono Telephone number: 020 7782 2324

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk . The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

vendor
Date   Source Headline
18th May 20261:25 pmRNSAIM Rule 17 and Schedule 2(g)
29th Apr 20267:00 amRNSc.£1.8m contract win with major UK telco
1st Apr 20267:00 amRNSBoard Update
26th Mar 20265:17 pmRNSNotification of major holdings
17th Mar 20267:00 amRNSInterim Results
17th Mar 20267:00 amRNSInterim Results
12th Mar 20267:00 amRNS£1.3m contract win with major UK telco
3rd Mar 20267:00 amRNSNotice of Results and Investor Presentation
3rd Feb 20267:00 amRNSc.£9m Contract renewal and expansion
30th Jan 20261:12 pmRNSTotal Voting Rights
15th Jan 20267:00 amRNSBoard Update
23rd Dec 20257:00 amRNSContract Expansion
23rd Dec 20257:00 amRNSContract Expansion
16th Dec 202511:09 amRNSResult of AGM
10th Dec 20257:00 amRNSBlock Admission
4th Dec 20257:00 amRNS£7.3m Contract Extension
24th Nov 20257:00 amRNSNotice of AGM
18th Nov 202510:12 amRNSDirector share purchases
11th Nov 20257:00 amRNSResults for the 15-month period ended 30 June 2025
30th Oct 20257:00 amRNSNotice of Results and Presentation
21st Jul 20253:45 pmRNSIssue of New Shares to Shearwater Group Plc
11th Jul 20259:40 amRNSNotification of major holdings
10th Jul 202510:00 amRNSGrant of LTIP Options
9th Jul 20257:00 amRNSFY25 Trading Update
29th May 20254:17 pmRNSNotification of major holdings
28th May 20257:00 amRNS-RSWG company achieves landmark AI Certification
7th May 20257:00 amRNS£4.4m New Contract Win
2nd Apr 20257:00 amRNSContract Renewal
19th Feb 20253:56 pmRNSDirector dealing
17th Feb 20252:32 pmRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSUpdate re Spanish Gold Licences
30th Jan 20257:00 amRNSChange of Year End and Grant of LTIP options
20th Dec 20247:00 amRNS£2.3m Contract wins
26th Nov 20247:00 amRNSInterim Results
20th Nov 20247:00 amRNSNotice of Investor Presentation
7th Nov 20247:00 amRNSContract Wins and Notice of Results
25th Sep 20243:59 pmRNSBoard Update
29th Aug 20245:42 pmRNSNotice of AGM and Posting of Annual Report
27th Aug 20247:00 amRNSCFO Appointment
24th Jul 20247:00 amRNSResults for the year ended 31 March 2024
19th Jul 202412:43 pmRNSContract Win and Notice of Results
3rd Apr 20247:00 amRNSFY24 Trading Update
4th Jan 20247:00 amRNSContract Wins
22nd Nov 20237:00 amRNSInterim Results
21st Nov 202311:18 amRNSChange of Nominated Adviser and Broker
20th Nov 20231:19 pmRNSBoard Update
3rd Nov 202310:12 amRNSNotice of Results and Board Appointment
10th Oct 20237:00 amRNSInterim CFO Appointment
5th Sep 20237:00 amRNSFinal Results
25th Aug 20237:00 amRNSUpdate re FY23 Results and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.